Borderline significant differences were observed in SAEs with frequency below 5%.
← all excerpts
Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study.
1
—
—
Borderline significant differences were observed in SAEs with frequency below 5%.